Appreciating Repositories
December 24, 2010
It's a great debate, and far from over. Some analysts predict the large contract research organizations (CRO) will eventually manage the bulk of industry-sponsored research. Others predict that mid-tier and specialty CROs will command a greater share of clinical trials as the giants struggle to take care of small customers as well as they pamper megaclients. Or…more...
Cancellations Subside
December 02, 2010
Have contract research organizations (CRO) turned the corner? Is the current downturn about to pass? Those were the questions we put to Michael Martorelli, director, Fairmount Partners.
Martorelli is a savvy Philadelphia-based observer of the CRO industry. By constitution, he is a plain-speaking and numbers-oriented guy who helps to find buyers and sellers for CROs; his firm…more...
Clinical Efficiencies
November 02, 2010
Les Rose appreciates the complexity of calculating costs in clinical trials. Principal of PharmaVision Consulting, a small consulting firm, he has been helping to run trials for a few decades, both independently and at his own small contract research organization (CRO). Rose says sponsors have learned to be tolerant of delay, indulgent of budget overruns.
"Lateness is…more...
Ugly Numbers
October 28, 2010
How bad are the job losses in pharma? How long will they last? As a starting point, every month brings new, grim numbers from Challenger, Gray & Christmas, a Chicago firm that specializes in executive recruiting.
Recent Challenger data suggest that, at the moment, the job losses in pharma are intensifying relative to other industries. In 2010,…more...
Clinical Efficiencies
Real Trial Budgets
A demo of ClearTrial software and an exploration of the roots of tolerance for imprecision.
Profile: Target Health
Ending Mindless Monitoring
Jules Mitchel discusses the lack of any rationale for 100 percent source document verification
October Special Report
Time, Materials & Self Deception
Should pharma still be modeling a key R&D process on the construction industry?
7 Questions For Core Labs
Modern Imaging Benchmarks
An executive from Merge tries to reset industry expectations for radiology-related trials in the age of the internet.
Schizophrenic RFPs?
PharmaNet On Late Phase
The company discusses what makes Phase IV projects different.
Quintiles At DIA
Toward Quality Trials
The big CRO discusses a proactive and data-driven approach to managing trials.
Part Two
Site Pain With EDC
A second installment of reflections on EDC from the perspective of clinical sites.
